CJC-1295 (No DAC), GHRP-2 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and GHRP-2 formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (No DAC), GHRP-6 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and GHRP-6 formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (no DAC), Hexarelin 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and Hexarelin formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC, Ipamorelin, and GHRP-2 formulation delivers an advanced, triple-action research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and distinct growth hormone secretagogue receptor signaling mechanics.
CJC-1295 No DAC (Modified GRF 1-29)+ Ipamorelin 10mg Blend
CJC-1295 No DAC Ipamorelin 10mg Blend 5mg CJC-1295 No DAC (Modified GRF 1-29) + 5mg Ipamorelin per vial. Lyophilised powder, dual-compound. ≥99% purity by HPLC. Third-party tested Janoshik Analytical. Heavy metals & endotoxin screened. COA verified per batch. USA-manufactured. $95.00 In stock. For laboratory research use only.
CJC-1295 no DAC 2mg (Mod GRF 1-29)
PRODUCT SHORT DESCRIPTION
CJC-1295 No DAC 2mg (Modified GRF 1-29) is a premium, high-purity synthetic peptide analogue engineered for advanced somatotropic signaling, neuroendocrine regulation, and pharmacokinetic stability research. This 2mg configuration provides a highly stable biochemical tool for investigating GHRH receptor affinity, adenylate cyclase activation, and pulsatile growth hormone mechanics.
CJC-1295 no DAC 5mg (Mod GRF 1-29)
PRODUCT SHORT DESCRIPTION
CJC-1295 No DAC 5mg (Modified GRF 1-29) is a premium, high-purity synthetic peptide analogue engineered for advanced somatotropic signaling, neuroendocrine regulation, and pharmacokinetic stability research. This 5000mcg configuration provides a highly stable biochemical tool for investigating GHRH receptor affinity, adenylate cyclase activation, and pulsatile growth hormone mechanics.
Fragment, Modified GRF, Ipamorelin 12mg (Blend)
PRODUCT SHORT DESCRIPTION
The Fragment, Modified GRF, and Ipamorelin formulation delivers an advanced, triple-action 12mg (12000mcg) research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility, and parallel lipid metabolism pathways.
GHRP-2 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-2 (5mg x 5) and CJC-1295 no DAC (5mg x 5)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing five 5mg vials of GHRP-2 alongside five 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-2 (5mg x 5) and Ipamorelin (5mg x 5)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing five 5mg vials of GHRP-2 alongside five 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.